- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04829500
Effectiveness and Implementation of Montessori Approaches in Person-Centered Care Within VA (MAP-VA)
Montessori Approaches in Person-Centered Care (MAP-VA): An Effectiveness-Implementation Trial in Community Living Centers
Background: Addressing behavioral and neuropsychiatric symptoms of Veterans with dementia and serious mental illness (SMI) such as schizophrenia can be challenging for staff in VA long-term care settings, called Community Living Centers or CLCs. These behaviors of distress (agitation, aggression, and mood disturbance) are not just associated with staff stress and burnout; they also hasten residents' functional decline, decrease quality of life, and increase mortality. Staff training in non-pharmacological interventions can be effective. Yet systems barriers, task-based care models, and time constraints often result in staff employing "quicker," less effective strategies. Montessori Approaches to Person-Centered Care for VA (MAP-VA)- a staff training, intervention, and delivery toolkit- developed in collaboration with VA operational partners, Veterans, and frontline CLC staff is positioned to respond to this challenge. The investigators' prior work shows probable impacts on CLC quality indicators at the individual and unit level (e.g., psychotropic medications, depressive symptoms, weight loss, falls, pain). The goal of this study is to evaluate the MAP-VA program and necessary supports for a successful implementation at 8 VA CLCs.
Significance/ Innovation: VHA's Modernization Plan focuses on empowering front-line staff to lead quality improvement efforts like the ones taught through MAP-VA. MAP-VA is distinct from existing interventions in its: 1) application to Veterans with a range of diagnoses and cognitive abilities; 2) emphasis on pairing practical skill-building for staff with overcoming system-level barriers that inhibit person-centered care; and 3) engagement of all staff rather than a reliance on provider-level champions. Yet, MAP-VA is a complex intervention that requires participation of multiple stakeholder groups, making implementation facilitation necessary. To date, no studies have evaluated MAP implementation success in operational settings (community or VA) and sustainability is rarely examined.
Aims: This 4-year study will examine both the effectiveness of the MAP-VA program on resident outcomes, person-centered care practices, and organizational culture as well as an evaluation of the implementation barriers to adopting MAP-VA in a sustainable way over a 12 month period. Staff and residents at 8 CLCs will participate in the study.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Specific Aims: A hybrid implementation-effectiveness study is necessary to evaluate MAP-VA for Veterans and staff in CLCs. Study Aims include: 1) evaluate implementation facilitation and identify barriers to MAP-VA adoption and fidelity; 2) determine effectiveness of MAP-VA implementation on resident behavioral, emotional, and physical health outcomes; 3) determine effectiveness of MAP-VA implementation on person-centered care practices and organizational culture; and 4) examine the extent to which MAP-VA is sustained after external facilitation support has ended.
Methodology: A stepped-wedge cluster randomized controlled trial will be used to evaluate within- and between-cluster implementation success and treatment effects over 18 months. Eight CLCs (approximately 24 CLC neighborhoods) will be randomized to a sequential crossover to the intervention with six months of facilitation. Sequential balancing will be used during randomization to balance the sample over time. Analyses will account for time trends and correlations within cluster. Normalization process theory and the RE-AIM evaluation framework will guide the implementation evaluation and integration of qualitative and quantitative data. Data sources include primary data collection (e.g., resident interviews, staff interviews, surveys, researcher observation) and existing VA administrative data (e.g., Minimum Data Set 3.0, pharmacy, annual employee survey).
The unit of analysis in hybrid implementation-effectiveness designs is typically at the system level (in the investigators' case the CLC/neighborhood) since existing staff provide the intervention. To address the research questions and corresponding aims, the study approach assesses both the clinical innovation (MAP-VA) and the implementation process itself (Blended Facilitation). Implementation process measures, fidelity, and outcome indicators will be tracked using a mixed methods evaluation approach. Common features of SW-CRTs utilized in this study include: 1) a baseline collection phase where no clusters are exposed to the intervention; 2) sequential randomized crossover to the intervention (MAP-VA), which cannot be reversed once it has been introduced; and 3) analyses that account for time trends and correlations within clusters. Randomization of facilities to MAP-VA will simply delay its rollout to sites randomized later in the sequence (like a wait-list control condition).
Target sample size and analyses. A sample size of more than 200 CLC Staff and 96 Veteran residents are anticipated. Qualitative interview data will be analyzed using a content analytic approach. To test Aims 2 and 3 (effectiveness of MAP-VA) on the primary effectiveness outcome, scores for residents in the pre-intervention control condition will be compared to scores from residents in the intervention condition. GEE models with an identity link will be used to examine and compare means over time, with time considered a random effect. An indicator term will denote if the observation is pre- or post- intervention implementation, thus representing whether there was an overall difference during the intervention period versus the pre-intervention period.
A centralized Data Safety Monitoring Board coordinated through the study sponsor (VA Health Services R&D) will convene to review study materials annually.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Tuscaloosa, Alabama, United States, 35404-5015
- Tuscaloosa VA Medical Center, Tuscaloosa, AL
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Residents who meet at least one of the following eligibility criteria will be eligible:
- dementia diagnosis or related disorder
- Cognitive Function Scale score indicative of impairment
- positive Patient Health Questionnaire (PHQ-9) depression score
- mental health diagnosis (e.g., ICD-10 codes)
- indication of agitation or aggression per MDS behavior items
- active prescription for a PRN or scheduled antipsychotic, sedative/hypnotic, or benzodiazepine/anxiolytic
Exclusion Criteria:
- Residents admitted for hospice or respite care
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Pre-Intervention Baseline Collection Phase
All sites will start with a baseline collection phase without exposure to the intervention, consistent with the stepped wedge cluster randomized trial design.
A sequential randomized crossover to the intervention (MAP-VA) will be assigned, which cannot be reversed once it has been introduced.
|
|
Experimental: MAP-VA Intervention
Montessori approaches to person-centered care (MAP-VA) introduces practical strategies that frontline staff can use for successful engagement of residents through retained abilities such as implicit learning, procedural memory, reading abilities.
Staff training provides practice with: 1) pre-developed activities and templates, 2) a simple reading assessment to inform development of external cues; and 3) identifying opportunities for increased independence and resident contribution to community routines.
Staff are also introduced to concrete strategies that improve dignity, control, and independence.
|
Montessori approaches to person-centered care (MAP-VA) introduces practical strategies that frontline staff can use for successful engagement of residents through retained abilities.
Staff are also introduced to concrete strategies that improve dignity, control, and independence.
MAP-VA is based on the work of Maria Montessori who demonstrated that a structured, supportive environment and meaningful, active roles in the classroom enabled children to fulfill their greatest potential physically, mentally, and emotionally.
Montessori principles have been applied to dementia care for more than 20 years to promote functional independence, meaningful engagement, and dignity.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in resident agitation from pre-intervention to post-intervention
Time Frame: Primary data collection occurs at 4 time points across 7 months (2 pre-intervention and 2 after the intervention has been initiated)
|
Staff-reported observations of resident agitation will be collected over time using the Cohen-Mansfield Agitation Inventory (CMAI).
The CMAI is a widely used, valid measure of agitation frequency for older adults across diagnoses in NH settings.
Staff rate 29 behaviors over the past two weeks (1=never to 7=several times/hr) across four subscales: verbally nonaggressive behaviors, verbally aggressive behaviors, physically nonaggressive behaviors, and physically aggressive behaviors.
Higher scores indicate more agitation.
|
Primary data collection occurs at 4 time points across 7 months (2 pre-intervention and 2 after the intervention has been initiated)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in resident mood from pre-intervention to post-intervention
Time Frame: Primary data collection occurs at 4 time points across 7 months (2 pre-intervention and 2 after the intervention has been initiated)
|
Resident symptoms of depression will be assessed using the 9-item Patient Health Questionnaire (PHQ-9) or the PHQ-Observational (PHQ-OV) for residents who cannot self-report mood symptoms.
Staff or residents will be asked to rate the frequency of symptoms over the past 2 weeks on a 4-point scale (0 = never or 1 day, to 3 = nearly every day).
Higher scores indicate more mood symptoms.
|
Primary data collection occurs at 4 time points across 7 months (2 pre-intervention and 2 after the intervention has been initiated)
|
Change in resident psychotropic medication use from pre-intervention to post-intervention
Time Frame: Monthly pharmacy data will be examined pre-and post-intervention for time trends.
|
Psychotropic medication use will be extracted for individual residents enrolled in the study as well as examined at the unit-level using pharmacy data.
Monthly administration rates of PRN anti-psychotics, benzodiazepines, and sedatives / hypnotics often used for agitation will be tracked.
|
Monthly pharmacy data will be examined pre-and post-intervention for time trends.
|
Change in patient-centered care practices / organizational culture from pre-intervention to post-intervention
Time Frame: Primary data collection occurs at 4 time points across 7 months (2 pre-intervention and 2 after the intervention has been initiated)
|
Staff-rated patient-centered care practices (e.g., atmosphere, individualized care and services) will be assessed using subscales of the Patient Centered Care Practices in Assisted Living (PC-PAL).
Items are rated on a 4-point scale from 1 = strongly disagree to 4 = strongly agree, with higher scores indicating higher patient-centered care practices.
|
Primary data collection occurs at 4 time points across 7 months (2 pre-intervention and 2 after the intervention has been initiated)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Michelle Marie Hilgeman, PhD, Tuscaloosa VA Medical Center, Tuscaloosa, AL
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIR 19-413
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia or a Related Disorder
-
Sohail RaoRecruitingSpecimens Are to be Collected From Subjects Who Are Having or Have Had a Fluid or Tissue Removed, a Biopsy or a Blood or Bone Marrow DrawUnited States
-
University Hospital, BordeauxCompletedAlzheimer's Disease or Related DisorderFrance
-
University of California, DavisCompletedDepression | Dementia | Substance Use Disorder | Anxiety Disorder | Mood DisorderUnited States
-
University of PennsylvaniaCompletedIn Need of a Pap Smear (Cervical Cancer Screening) | In Need of a Blood Pressure Check (Hypertension Screening) | In Need of a Cholesterol Test (Lipid Disorder Screening) | In Need of a Fasting Plasma Glucose Test (Diabetes)United States
-
University Hospital, LilleNot yet recruitingPatient Treated With Lithium, With Bipolar or Schizo-affective Disorder, Hospitalized in a Psychiatric Ward
-
MD Stem CellsEnrolling by invitationAlzheimer Disease | Traumatic Brain Injury | Autism Spectrum Disorder | Lewy Body Disease | Vascular Dementia | Autism | Dementia, Mixed | Alzheimer Dementia | Dementia, Multi-Infarct | Cadasil | Parkinson-Dementia Syndrome | Chronic Traumatic Encephalopathy | Autistic Behavior | Lewy Body Dementia With Behavioral... and other conditionsUnited States, United Arab Emirates
-
Max-Planck-Institute of PsychiatryCompletedSchizophrenia | Schizoaffective Disorder | Delusional Disorder | Schizotypal Disorder | Brief Psychotic Disorder | Shared Psychotic Disorder | Other Psychotic Disorder Not Due to A Substance or Known Physiological Condition | Unspecified Psychosis Not Due to a Substance or Known Physiological Condition and other conditionsGermany
-
Weill Medical College of Cornell UniversityUnknownDiagnosis of a Pancreaticobiliary DisorderUnited States
-
Institut de Sante Publique, d'Epidemiologie et...CompletedAlzheimer Disease or Associated Disorder | Mild to Moderately Severe DementiaFrance
-
University of OxfordUniversity College, LondonCompletedCognitive Impairment | Dementia | Affective DisordersUnited Kingdom
Clinical Trials on Montessori Approaches to Person-Centered Care (MAP-VA)
-
University of California, San FranciscoNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute... and other collaboratorsRecruiting